Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al.

Circulation. 1987 Jul;76(1):142-54.

PMID:
3109764
2.
3.

Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?

Collen D.

Ann Intern Med. 1990 Apr 1;112(7):529-38. Review.

PMID:
2107781
4.

Thrombolytic treatment in acute myocardial infarction.

Verstraete M.

Circulation. 1990 Sep;82(3 Suppl):II96-109. Review.

PMID:
2118432
5.

Designing thrombolytic agents: focus on safety and efficacy.

Collen D.

Am J Cardiol. 1992 Jan 3;69(2):71A-81A. Review.

PMID:
1729881
6.

[New thrombolytic agents in myocardial infarction].

Charbonnier B, Lang M, Brochier M.

Arch Mal Coeur Vaiss. 1987 Nov;80(12):1785-91. Review. French.

PMID:
3128222
7.

[t-PA in thrombolytic therapy of acute myocardial infarct].

Rutsch W, Schmutzler H.

Herz. 1994 Dec;19(6):336-52. Review. German.

PMID:
7843690
8.

Thrombolytic therapy in Europe: current status.

Vahanian A.

Eur Heart J. 1996 Sep;17 Suppl E:21-7. Review.

9.

New developments in thrombolytic therapy.

Collen D, Gold HK.

Adv Exp Med Biol. 1990;281:333-54. Review.

PMID:
2129372
10.

Thrombolytic therapy in acute myocardial infarction: Part II--rt-PA.

Mueller HS, Roberts R, Teichman SL, Sobel BE.

Med Clin North Am. 1989 Mar;73(2):387-407. Review.

PMID:
2493116
11.

Comparison of thrombolytic agents: selected hematologic, vascular and clinical events.

Marder VJ.

Am J Cardiol. 1989 Jul 5;64(2):2A-7A; discussion 24A-26A. Review.

PMID:
2662739
12.

Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction.

Barradell LB, Goa KL.

Pharmacoeconomics. 1995 Nov;8(5):428-59. Review.

PMID:
10172669
13.

New developments in thrombolytic therapy.

Collen D, Gold HK.

Verh K Acad Geneeskd Belg. 1989;51(3):191-228; discussion 229. Review.

PMID:
2686261
14.

Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.

Gillis JC, Goa KL.

Pharmacoeconomics. 1996 Sep;10(3):281-310. Review.

PMID:
10163575
15.

Advances in thrombolytic therapy for acute myocardial infarction.

Topol EJ.

J Clin Pharmacol. 1987 Oct;27(10):735-45. Review.

16.

Reperfusion therapy in inferior myocardial infarction.

Bates ER.

J Am Coll Cardiol. 1988 Dec;12(6 Suppl A):44A-51A. Review.

PMID:
3142944
17.

[Thrombolytic treatment in the acute phase of myocardial infarction. Evaluation in 1986].

Kher A, Michel PL, Samama M, Acar J.

Ann Med Interne (Paris). 1986;137(7):584-9. Review. French.

PMID:
3545003
18.

Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.

Battershill PE, Benfield P, Goa KL.

Drugs Aging. 1994 Jan;4(1):63-86. Review.

PMID:
8130384
19.

Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.

Diefenbach C, Erbel R, Pop T, Mathey D, Schofer J, Hamm C, Ostermann H, Schmitz-Hübner U, Bleifeld W, Meyer J.

Am J Cardiol. 1988 May 1;61(13):966-70. Review.

PMID:
2452563
20.

New developments in thrombolytic therapy.

Collen DC, Gold HK.

Thromb Res Suppl. 1990;10:105-31. Review.

PMID:
2180114
Items per page

Supplemental Content

Support Center